JUMP REPORT
TILRAY (TLRY)
EARNINGS RELEASE - AUGUST 10 (AMC)
EARNINGS EXPECTATIONS:
THIS QTR: EPS: -.27/share REV: 55.02/M
___________________________________________________________
LAST QTR: EPS: -.45/share ACTUAL: -1.73/share (MISS)
____________________________________________________________
NEXT QTR: EPS: -.24/share REV: 60.15/M
____________________________________________________________
FULL YR: EPS: -2.27/share REV: 237.68/M
____________________________________________________________
BEAT/MISS RECORD: 14% OF THE TIME THEY BEAT ESTIMATES
PRIOR ‘JUMP ZONE’ MOVES (LAST 3 QTRS %) -8.66, -15.3, -3.01
EXPECTED JUMP MOVE THIS QUARTER: 10-12%
——–
*** With market volatility at extremes there is greater risk in trading these events which may not react as they would under normal market conditions. Please take extra caution before tradin
Links To Latest News and Headlines
New Broken Coast Summer Launch Expands the Brand’s Premium Craft Lineup Alongside an Elevated Packaging Redesign TORONTO, May 28, 2026 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the cannabis, beverage, and wellness industries, today announced the launch of Cherry Ztripez, a new premium craft cannabis strain under its Broken Coast brand. Arriving just in time for summer,
BrewDog Launches Multi-Channel “Underdog” Campaign Across Retail, Bars and Digital Media — Including a Nationwide “Win a Year of Beer” Contest and Destination Match-Day Watch Parties Across the U.K. ELLON, United Kingdom, May 27, 2026 (GLOBE NEWSWIRE) — BrewDog, one of the U.K.’s leading and most recognizable craft beer brands, part of Tilray Brands, Inc. (NASDAQ: TLRY; TSX: TLRY), is launching one of its biggest-ever summer campaigns, transforming bars, retail and digital platforms across the
Don’t hold your breath.
Industry Leaders Convene on the Future of Medical Cannabis Regulation and Patient AccessLONDON, May 26, 2026 (GLOBE NEWSWIRE) — Tilray Medical, a global leader in medical cannabis research, cultivation, production, products and distribution and a division of Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), today announced its participation in Cannabis Europa London 2026, one of Europe’s leading forums for medical cannabis policy, science, and regulation. Cannabis Europa London 2026 wil
Tilray stock reaction to U.S. policy news and new Carlsberg partnership Tilray Brands (TLRY) is back in focus after U.S. cannabis reclassification headlines, a fresh multi-year partnership with Carlsberg, and a recent share price decline even as many cannabis peers gained. See our latest analysis for Tilray Brands. Despite the policy headlines and new Carlsberg partnership, Tilray’s share price has fallen 32.78% over the past month and 45.58% year to date, while the 1 year total shareholder…
StockJumpers analysis and trade plans are finalized and uploaded generally one house before market cloase (3PM EST) for most events unless noticed.
“I’m sorry, this content is for members only. To access this content, you must log in with your membership credentials – OR if you are not a member yet, visit our registration page here and get signed up Looking forward to having you on-board ASAP”
There is a significant amount of data behind the scenes involved in the analysis and trade plan tab above, that does not get put into the report. Too much information for traders often confuses things – so this is stripped down to only what is needed to make the best possible decision(s) on trading the trajectory.
Members who are too busy to manual trade can use Trade Assist. For more information visit here
| Avg Daily Volume: 9,055,059 Market Cap: 946.45M Sector: Consumer Durables Short Interest: 19.43 |
Ticker delayed 20 minutes
NOTICE: All material on this site has been published for informational and educational purposes only and does not constitute an offer to sell nor a solicitation of an offer to buy any security which may be referenced here or in our websites. StockJumpers is not an Investment Adviser and relies on the publisher’s exemption as defined in Section 401(f) of the Uniform Securities Act, and provides no personal advice or recommendations. The services and published information contained herein is for non-commercial, educational use and display. StockJumpers and any of its affiliates does not represent that the securities or services discussed are suitable for any investor. You should assume that StockJumpers and or its management has or will take a position in the stock, whether it is stated or not. You are further advised not to rely on any information contained in this report and associated websites in the process of making a fully informed investment decision. Trading is risky and you can lose your investment. For the complete risk disclosure and other legal information please review the full Terms of Use Agreement.